Brussels, April 1, 2020 – In response to urgent needs by medical professionals for protective equipment to combat COVID-19, Solvay is supplying high-performance, medical-grade transparent film to Boeing for its production of face shields. Boeing approached Solvay due to its experience in the use of advanced composite and adhesive materials on multiple commercial and defense programs.
Manufactured by Solvay's Ajedium™ Films business, the thermoplastic film will be used by Boeing in the production of thousands of face shields critically needed by hospitals and medical workers in the U.S. to protect them from the COVID-19 virus. The film will be manufactured using Solvay’s medical-grade Radel® PPSU or Udel® PSU, two transparent specialty polymers widely used for medical devices because of their ability to be sterilized and withstand aggressive disinfectants.
"We are honored to bring our product expertise to our customers in this time of crisis," explains Jeff Hrivnak, healthcare global business development manager for Solvay Specialty Polymers. "Boeing is rising to the occasion by providing more durable, face shields now in critical demand for our heroic healthcare workers, and we are proud to help make that possible."
Further product and contact information are available on Solvay's dedicated page on COVID-19 emergency production.
About SolvaySolvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 24,100 employees in 64 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet plan crafted around three pillars: protecting the climate, preserving resources and fostering better life. The Group’s innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world’s top three companies for the vast majority of its activities and delivered net sales of €10.2 billion in 2019. Solvay is listed on Euronext Brussels (SOLB) and Paris and in the United States, where its shares (SOLVY) are traded through a Level I ADR program. Learn more at www.solvay.com. |